People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Viseon, Inc. | — | Other Technology | Series B | $32.0M | $20.0M | 2020 |
| Reverse Medical Corp | — | Other Technology | Series A | $28.1M | $383.1M | 2009 |
| Rebound Therapeutics Corp | — | Pharma | Series B | $20.3M | $561.1M | 2015 |
| Magellan Spine Technologies Inc | — | Other Technology | Pre-Seed | $618K | $26.2M | 2009 |
Jeffrey J. Valko at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey J. Valko on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael R. Henson | 4 | 9 |
| Tracy R. Pearson | 1 | 2 |
| JOHN GEIS | 1 | 2 |
| Benjamin C. Tsai | 1 | 2 |
| Aris Constantinides | 1 | 2 |
| Peter C. Davis | 1 | 1 |
| Paul J. Meiyal | 1 | 1 |
| John J. Yianni | 1 | 1 |
| Aris J. Constantinides | 1 | 1 |
| John Yianni | 1 | 1 |
| E Scott Conner | 1 | 1 |
| Jill Tracy Pearson | 1 | 1 |
| Peter G Davis | 1 | 1 |
| Ron R. Bache | 1 | 1 |
| Rachel Tracy Reginato | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.